Fredun Pharmaceuticals (NSE:FREDUN) Total Liabilities: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:FREDUN Fredun Pharmaceuticals Ltd NSE:FREDUN
60 GF Score
Price ₹1,428.00
GF Value ₹600.96
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fredun Pharmaceuticals Total Liabilities?

Fredun Pharmaceuticals NSE:FREDUN 60 Total Liabilities is ₹0.00 Mil as of Jun. 2026. GuruFocus rates NSE:FREDUN with a GF Score™ of 60/100 and a GF Value™ of ₹600.96 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Fredun Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Fredun Pharmaceuticals's quarterly Total Liabilities increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹3,604.61 Mil) but then declined from Mar. 2026 (₹3,604.61 Mil) to Jun. 2026 (₹0.00 Mil).

Fredun Pharmaceuticals's annual Total Liabilities increased from Mar. 2024 (₹1,861.28 Mil) to Mar. 2025 (₹3,460.29 Mil) and increased from Mar. 2025 (₹3,460.29 Mil) to Mar. 2026 (₹3,604.61 Mil).

Fredun Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Fredun Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fredun Pharmaceuticals Total Liabilities Chart

Fredun Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,189.28 1,609.04 1,861.28 3,460.29 3,604.61

Fredun Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3,069.26 0.00 3,604.61 0.00
NSE:FREDUN
60GF Score
Fredun Pharmaceuticals Ltd NSE:FREDUN
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fredun Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Fredun Pharmaceuticals's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2968.61+(563.103+30.342
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+42.555+0)
=3,604.61

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=6420.823-2816.213
=3,604.61

Fredun Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=N/A

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹0.00 Mil mean?
Fredun Pharmaceuticals (NSE:FREDUN) has a Total Liabilities of ₹0.00 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Fredun Pharmaceuticals and its competitors.
Is Fredun Pharmaceuticals' Total Liabilities too high?
Fredun Pharmaceuticals' current Total Liabilities is ₹0.00 Mil. Overall, Fredun Pharmaceuticals has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fredun Pharmaceuticals' Total Liabilities compare to ?
Fredun Pharmaceuticals' Total Liabilities of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Fredun Pharmaceuticals and its competitors. Fredun Pharmaceuticals's current Total Liabilities is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fredun Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Fredun Pharmaceuticals (NSE:FREDUN) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹600.96, compared to a current price of ₹1,428.00 — trading 137.6% above its estimated fair value. The current Total Liabilities is ₹0.00 Mil. Fredun Pharmaceuticals' overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Fredun Pharmaceuticals (NSE:FREDUN), the current Total Liabilities is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fredun Pharmaceuticals (NSE:FREDUN) Overvalued in 2026?

Based on GuruFocus' analysis, Fredun Pharmaceuticals stock appears to be overvalued. The current stock price of ₹1,428.00 is trading 137.6% above its estimated GF Value™ of ₹600.96. GuruFocus considers Fredun Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:FREDUN:

  • Total Liabilities: ₹0.00 Mil
  • GF Value™: ₹600.96 vs. price of ₹1,428.00 (137.6% above fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the NSE:FREDUN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fredun Pharmaceuticals Business Description

Comparable Companies
Other Exchanges 539730:India
Address Ganpatrao Kadam Marg, Delisle Road, 11th Floor, Urmi Estate 95, Lower Parel (West), Mumbai, MH, IND, 400013
Fredun Pharmaceuticals Ltd in its Endeavour to move ahead has now ventured into manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products also with products ranging from allopathic formulations to on field diagnostic kits, Company's main objective is to be a holistic healthcare provider. The group is dedicated to improving lives of people. The Company operates only in a single segment i.e. Pharmaceutical Segment. The company has presence in Domestic as well as International market. The company generates majority of revenue from Domestic market.
60GF Score

Get the complete analysis for NSE:FREDUN

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,428.00
Price
₹600.96
GF Value